Norwegian hope for a SARS vaccine - The Norwegian firm Bionor has started work on developing what may be the first vaccine against the SARS virus.

Return to Vaccination News Home Page

Subscribe to the Vaccination NewsLetter

View past & current Scandals (columns by Sandy Mintz)

Return to Vaccination News Home Page

DISCLAIMER: All information, data, and material contained, presented, or provided here is for general information purposes only and is not to be construed as reflecting the knowledge or opinions of the publisher, and is not to be construed or intended as providing medical or legal advice. The decision whether or not to vaccinate is an important and complex issue and should be made by you, and you alone, in consultation with your health care provider.


17. Mai 2003 Norwegian hope for a SARS vaccine The Norwegian firm Bionor has started work on developing what may be the first vaccine against the SARS virus. The Skien-based firm has valuable experience, according to the Norwegian Institute for Public Health. The research will be carried out in cooperation with the Institute for Puplic Health. The Institute has asked Bionor to take on the task, since it already has experience working on a test vaccine against HIV. Researechers at Bionor have worked on the SARS vaccine for more than a month already, and hope to have it ready for testing in another eight months, NRK reports. (NRK) Rolleiv Solholm